Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 1
1917 2
1920 2
1921 1
1922 1
1923 1
1925 2
1926 4
1927 2
1928 4
1929 4
1930 6
1932 3
1933 1
1934 3
1935 5
1936 2
1937 4
1938 7
1939 4
1940 7
1941 2
1942 7
1943 10
1944 6
1945 11
1946 14
1947 9
1948 15
1949 18
1950 30
1951 29
1952 38
1953 26
1954 33
1955 36
1956 54
1957 48
1958 58
1959 50
1960 57
1961 67
1962 59
1963 56
1964 80
1965 111
1966 113
1967 124
1968 147
1969 164
1970 217
1971 200
1972 252
1973 251
1974 239
1975 987
1976 1085
1977 1034
1978 1037
1979 1134
1980 1188
1981 1193
1982 1253
1983 1414
1984 1465
1985 1403
1986 1475
1987 1516
1988 1489
1989 1818
1990 1941
1991 1832
1992 1889
1993 1844
1994 1811
1995 1875
1996 1803
1997 1827
1998 1861
1999 1861
2000 1843
2001 1707
2002 1712
2003 1776
2004 1797
2005 2037
2006 2122
2007 2056
2008 2089
2009 2137
2010 2364
2011 2658
2012 2656
2013 2643
2014 2714
2015 2657
2016 2567
2017 2508
2018 2473
2019 2471
2020 2910
2021 4074
2022 4696
2023 3677
2024 1262

Text availability

Article attribute

Article type

Publication date

Search Results

96,277 results

Results by year

Filters applied: . Clear all
Page 1
Anti-A and anti-B: what are they and where do they come from?
Branch DR. Branch DR. Transfusion. 2015 Jul;55 Suppl 2:S74-9. doi: 10.1111/trf.13087. Transfusion. 2015. PMID: 26174901 Review.
All of the donors being used for IVIG production, with the exception of group AB donors, have in their plasma antibodies of variable titer commonly known as isohemagglutinins or ABO antibodies. ...In addition, a brief discussion of the controversial topic of …
All of the donors being used for IVIG production, with the exception of group AB donors, have in their plasma antibodies of variable …
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Follmann D, O'Brien MP, Fintzi J, Fay MP, Montefiori D, Mateja A, Herman GA, Hooper AT, Turner KC, Chan KC, Forleo-Neto E, Isa F, Baden LR, El Sahly HM, Janes H, Doria-Rose N, Miller J, Zhou H, Dang W, Benkeser D, Fong Y, Gilbert PB, Marovich M, Cohen MS. Follmann D, et al. Nat Commun. 2023 Jun 17;14(1):3605. doi: 10.1038/s41467-023-39292-w. Nat Commun. 2023. PMID: 37330602 Free PMC article. Clinical Trial.
While new vaccines for SARS-CoV-2 are authorized based on neutralizing antibody (nAb) titer against emerging variants of concern, an analogous pathway does not exist for preventative monoclonal antibodies. ...These data quantitate a nAb titer correlate …
While new vaccines for SARS-CoV-2 are authorized based on neutralizing antibody (nAb) titer against emerging variants of conce …
Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis.
Bito T, Nishikawa R, Hatakeyama M, Kikusawa A, Kanki H, Nagai H, Sarayama Y, Ikeda T, Yoshizaki H, Seto H, Adachi A, Horikawa T, Oka M, Nishigori C. Bito T, et al. Br J Dermatol. 2014 Apr;170(4):922-9. doi: 10.1111/bjd.12791. Br J Dermatol. 2014. PMID: 24329764
RESULTS: We observed a 50% positive rate of ADAs to adalimumab, and a 41% positive rate of ADAs to infliximab. The titres of ADAs showed a wide range from low to high titres. In the high-titre groups, the patients exhibited a decreased clinical response, and …
RESULTS: We observed a 50% positive rate of ADAs to adalimumab, and a 41% positive rate of ADAs to infliximab. The titres of ADAs sho …
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies.
Jazbec K, Jež M, Žiberna K, Mali P, Ramšak Ž, Potokar UR, Kvrzić Z, Černilec M, Gracar M, Šprohar M, Jovanovič P, Vuletić S, Rožman P. Jazbec K, et al. Virol J. 2023 Mar 27;20(1):53. doi: 10.1186/s12985-023-02007-0. Virol J. 2023. PMID: 36973781 Free PMC article.
The efficacy of this therapy depends on the quantity of neutralizing antibodies (NAbs) in the CCP units, with titers 1:160 being recommended. ...CONCLUSION: A simple quantitative serological determination of anti-SARS-CoV-2 antibodies alone is satisfactory fo …
The efficacy of this therapy depends on the quantity of neutralizing antibodies (NAbs) in the CCP units, with titers 1:160 bei …
High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors.
Aguilar G, Ortiz N, Gonzales D, Loyola S, Paredes JA. Aguilar G, et al. Transfus Apher Sci. 2022 Jun;61(3):103341. doi: 10.1016/j.transci.2021.103341. Epub 2021 Dec 10. Transfus Apher Sci. 2022. PMID: 34916156
One in two or three platelet donors, depending on the cutoff point used to define a critical IgM titer, had at least one critical titer of anti-A or anti-B antibodies. Early identification of platelet donors with critical antibody titers could p …
One in two or three platelet donors, depending on the cutoff point used to define a critical IgM titer, had at least one critical …
High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV.
Sasaki H, Miyata N, Yoshimura Y, Tachikawa N. Sasaki H, et al. Infection. 2022 Jun;50(3):771-774. doi: 10.1007/s15010-022-01779-x. Epub 2022 Feb 18. Infection. 2022. PMID: 35181864 Free PMC article.
We assessed the antibody titers among patients who received REGN-COV with the purpose of evaluating this therapeutic and prophylactic option from the serological point of view. METHODS: We collected serological data of patients with COVID-19 who were treated with RE …
We assessed the antibody titers among patients who received REGN-COV with the purpose of evaluating this therapeutic and proph …
Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients.
Kaduskar O, Gurav YK, Deshpande K, Desphande GR, Yadav P, Rakhe A, Tilekar BN, Gomade P, Salunke A, Patil C, Dange V, Salve P, Patsute S, Abraham P, Sapkal GN. Kaduskar O, et al. Indian J Med Res. 2022 May-Jun;155(5&6):565-569. doi: 10.4103/ijmr.IJMR_675_21. Indian J Med Res. 2022. PMID: 36124504 Free PMC article.
METHODS: A total of 463 serum samples from 218 SARS-CoV-2 PCR-positive patients were collected over a period of 124 days post-onset of disease (POD). Antibody levels were measured by chemiluminescence bioanalyzer. Neutralizing antibody titres were assessed by …
METHODS: A total of 463 serum samples from 218 SARS-CoV-2 PCR-positive patients were collected over a period of 124 days post-onset of disea …
Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19.
Park JH, Cha MJ, Choi H, Kim MC, Chung JW, Lee KS, Jeong DG, Baek MS, Kim WY, Lim Y, Yoon SW, Choi SH. Park JH, et al. J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):1094-1100. doi: 10.1016/j.jmii.2022.04.005. Epub 2022 May 5. J Microbiol Immunol Infect. 2022. PMID: 35570185 Free PMC article.
BACKGROUND: It remains unclear whether high titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies aggravate clinical manifestations in patients or whether severe clinical manifestations result in high antibody titers. ...The …
BACKGROUND: It remains unclear whether high titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies …
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
Bresciani L, Salvalaggio A, Vegezzi E, Visentin A, Fortuna A, Anglani M, Cacciavillani M, Masciocchi S, Scaranzin S, Carecchio M, Martinuzzi A, Gastaldi M, Briani C. Bresciani L, et al. J Peripher Nerv Syst. 2023 Sep;28(3):522-527. doi: 10.1111/jns.12565. Epub 2023 Jun 3. J Peripher Nerv Syst. 2023. PMID: 37246762
Improvement after anti-CD20 monoclonal antibody therapy has been reported. Data on Caspr1 antibodies pathogenicity are still preliminary, and longitudinal titers have been poorly described. METHODS: We report on a young woman who developed a disabling neuropa …
Improvement after anti-CD20 monoclonal antibody therapy has been reported. Data on Caspr1 antibodies pathogenicity are still p …
Standardization of ABO antibody titer measurement at laboratories in Korea.
Lim YA, Kang SJ. Lim YA, et al. Ann Lab Med. 2014 Nov;34(6):456-62. doi: 10.3343/alm.2014.34.6.456. Epub 2014 Oct 28. Ann Lab Med. 2014. PMID: 25368821 Free PMC article.
BACKGROUND: Measurement of the ABO antibody (Ab) titer is important in ABO-incompatible transplantation. However, to the best of our knowledge, no standard protocol or external survey program to measure the ABO Ab titer has been established in Korea. We inves …
BACKGROUND: Measurement of the ABO antibody (Ab) titer is important in ABO-incompatible transplantation. However, to the best …
96,277 results
You have reached the last available page of results. Please see the User Guide for more information.